Seoul National University Bundang Hospital (SNUBH)
Crohn's disease treatment cost in South Korea typically runs from AUD $1,445 to AUD $2,167 for essential capsule endoscopy, while specialized stem cell therapy ranges from AUD $1,011 to AUD $10,691. Total expenses depend on disease severity, the need for surgical intervention, and the chosen medication protocol. Patients often save approximately 40–60% compared to private healthcare costs in Australia and the United States. Seoul and Incheon are the primary medical hubs.
Typical Crohn's Disease Treatment Costs in South Korea
Bookimed Expert Insight: Patients with complex inflammatory bowel disease benefit from South Korea's highly digitalised hospital infrastructure. Severance Hospital holds JCI accreditation, which provides an extra layer of safety for international patients. Those seeking alternative protocols for refractory cases can access specialised arterial stem cell delivery at RE:YOUTH. Expert gastroenterologists like Dr Cheon Won Seok routinely perform capsule endoscopy for non-invasive bowel monitoring.
| Republic of Korea | Thailand | Turkey | |
| Stem Cell Therapy | from AUD $1,046 | from AUD $2,600 | from AUD $10,402 |
| Resection of gallbladder | from AUD $8,379 | from AUD $4,334 | from AUD $4,190 |
| Hormone therapy | from AUD $2,889 | from AUD $2,600 | from AUD $576 |
| Selective Apheresis | - | - | from AUD $2,239 |
No hidden fees – just official clinic prices. Pay at the clinic for Crohn's disease treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Crohn's disease treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Crohn's disease treatment journey.
Dr. Cheon Won Seok is the Director of Gastroenterology at Naeun Hospital in Incheon. He is a recognized medical advisor for major South Korean networks like KBS and MBC. Dr. Cheon is a board-certified subspecialist in gastrointestinal endoscopy. He works at a KOIHA-accredited facility that treats 20,000 patients annually.
South Korean tertiary hospitals offer treatments for complex Crohn's disease. These include mesenchymal stem cell therapy for perianal fistulas. Specialists use biologic therapies like infliximab and vedolizumab alongside multidisciplinary surgical care. Facilities like Severance Hospital and Asan Medical Center provide these specialised IBD protocols.
Bookimed Expert Insight: Major centres like Asan Medical Center handle high patient volumes. However, specialists like Dr Jin Yong Kim studied at Johns Hopkins and Harvard. This provides unique value for Australians. These doctors understand global clinical standards and offer smoother communication.
Patient Consensus: Patients note that fistulas rarely heal with medication alone. They often require a combined approach of surgery and biologics in Korea. Patients suggest bringing clear imaging records. You should confirm the hospital has a dedicated colorectal surgeon and IBD team before travelling.
Biologic therapies for Crohn's disease are readily available in the Republic of Korea. Major Seoul hospitals offer anti-TNF agents, vedolizumab, and ustekinumab for moderate-to-severe cases. These treatments follow guidelines from KASID (Korean Association for the Study of Intestinal Diseases).
Bookimed Expert Insight: South Korea's gastroenterology landscape is highly digitalised. Seoul National University Hospital has used electronic systems since 2004. This allows doctors to track long-term biologic responses with precision. Patients should choose JCI-accredited university hospitals to access the latest drug classes.
Patient Consensus: Patients note that major university hospitals in big cities provide these specialised drugs. They suggest bringing full pathology and colonoscopy reports to help the specialist consultation in Korea.
Treatment pathways in South Korea follow a structured step-up approach. Specialists prioritise early medical intervention using 5-aminosalicylates and immunomodulators before moving to biologics. Major tertiary centres in Seoul integrate diagnostics with minimally invasive surgery for complex cases.
Bookimed Expert Insight: Most Korean centres follow a traditional step-up protocol. However, the concentration of expertise at major Seoul facilities is exceptional. Large institutions like Severance Hospital and Seoul National University Hospital handle millions of patients annually. This volume allows doctors such as Dr Cheon Won Seok to specialise specifically in inflammatory bowel disease. For patients, this means accessing specialists who manage thousands of Crohn's cases. This often leads to more precise medication adjustments.
Patient Consensus: Patients note the speed of accessing specialist appointments and imaging in South Korea. This includes scans such as MRI or CT. Many suggest confirming if a clinic moves to biologics quickly or follows a slower timeline.